Inflation Reduction Act Imposes Prescription Drug Pricing Reforms
Healthcare Law Insights blog
NOVEMBER 8, 2022
The Act includes provisions targeting Medicare prescription drug costs, which could have wide-ranging effects for any party involved in the pharmaceutical industry, including drug developers, researchers, manufacturers, distributors, insurance companies, pharmacy associations and consumers. Small Biotech” drugs are also excluded until 2029.
52 
Let's personalize your content